ESTROGEN

What is it? Estrogen is a group of hormones primarily synthesised in the ovaries, with additional production occurring in fat cells and the adrenal glands. Estrogen receptors are distributed widely throughout the body, influencing various physiological processes including reproductive function, bone health, cardiovascular health, and cognitive function.

Premenopause: Estrogen levels fluctuate across the menstrual cycle, peaking during the follicular phase to stimulate the growth of ovarian follicles and promote the thickening of the endometrial lining¹.

Perimenopause: Declining estrogen levels during perimenopause are associated with irregular menstrual cycles, vasomotor symptoms (e.g., hot flashes and night sweats), vaginal dryness, and changes in mood².

Menopause and Postmenopause: Persistent low estrogen levels post-menopause contribute to symptoms such as vaginal dryness, osteoporosis, and an increased risk of cardiovascular disease³.

PROGESTERONE:

What is it? Progesterone is a hormone that plays a critical role in the female reproductive system. It is produced primarily in the ovaries following ovulation each month and is crucial for preparing the endometrium for implantation and supporting early pregnancy⁴.

Premenopause: Progesterone levels fluctuate cyclically, reaching their peak during the luteal phase to maintain the endometrium and support pregnancy⁵.

Perimenopause: Declining progesterone levels contribute to irregular menstrual cycles and may impact mood and sleep patterns as ovarian function declines⁶.

Menopause and Postmenopause: Absence of progesterone production post-menopause accompanies the cessation of menstrual cycles and contributes to hormonal imbalance symptoms⁷.

FSH and LH:

What are they? Follicle-Stimulating Hormone (FSH) and Luteinising Hormone (LH) are gonadotropins secreted by the anterior pituitary gland that regulate ovarian function.

Premenopause: FSH stimulates follicular development and estrogen production, while LH triggers ovulation and promotes progesterone production⁸.

Perimenopause: Elevated FSH and LH levels in perimenopause reflect diminished ovarian reserve and contribute to symptoms such as hot flashes, night sweats, and menstrual irregularities⁹.

Menopause and Postmenopause: Persistently elevated FSH and LH levels post-menopause indicate decreased ovarian function and are associated with hypoestrogenic symptoms and bone loss¹⁰.

TESTOSTERONE:

What is it? Although predominantly considered a male hormone, testosterone a hormone, produced in smaller amounts in women, primarily by the ovaries and adrenal glands.

Premenopause: Testosterone plays a role in maintaining libido, muscle mass, bone density, and overall well-being in women¹¹.

Perimenopause: Gradual decline in testosterone levels during perimenopause may contribute to decreased libido, reduced muscle strength, and changes in mood¹².

Menopause and Postmenopause: Further decline in testosterone post-menopause may exacerbate symptoms of sexual dysfunction, fatigue, and decreased muscle mass¹³.

Before 1 Month 🌿

PERI:

As hormones start to fluctuate in perimenopause, ingredients like soy isoflavones (40mg) can begin to support estrogen balance. Damiana Leaf (145mg) contributes to mood and hormonal stability, while amino acids like L-Arginine, L-Glutamine, and Taurine help support early energy and mental sharpness.

MENO:

For those already in menopause, Pumpkin Seed Extract (500mg) in MENO begins supporting bladder control and urinary comfort — a common issue in this phase.

1 Month and After ⚡

PERI:

At this stage, the adaptogenic effects of Siberian Ginseng (100mg) and Damiana in PERI may kick in, helping your body respond better to stress, while promoting mental clarity and calm.

Amino acids continue supporting physical resilience and energy production.

MENO:

Pumpkin Seed Extract (500mg) continues strengthening bladder muscles.

Hops (80mg) and Sage Leaf offer gentle hormonal support, potentially easing hot flashes and mood swings.

3 Months and After 🧠

PERI:

By month three, adaptogens and amino acids work more consistently to support brain fog, mood balance, and energy.

Soy isoflavones (40mg) reach full hormonal support potential with sustained use.

MENO:

Dong Quai Root (50mg) may start offering relief from symptoms like hot flashes and dryness.

CoQ10 (150mg) continues to support cellular energy, and Kelp (100mg) helps maintain healthy thyroid function — key for mood and metabolism.

✅ This is the stage where many women begin to notice significant improvements in both PERI and MENO: less brain fog, more energy, better hormone balance.

1 Year and After 🌸

PERI & MENO:

With consistent daily use, both formulas help sustain hormone balance, energy, and mood.

In PERI, soy isoflavones, Damiana, and adaptogens continue to support hormonal transitions.

In MENO, ongoing benefits from Pumpkin Seed Extract, CoQ10, and Dong Quai help maintain bladder, cardiovascular, and emotional health.

Antioxidants like Grape Seed, Green Tea Extract, and Resveratrol support cellular health and graceful aging in both blends.

We understand that many women want a natural, non-hormonal alternative to support their journey through perimenopause and menopause. While HRT can be effective for some, it’s not suitable for everyone — and may come with unwanted side effects like nausea, headaches, or digestive issues.

Our PERI and MENO blends offer a gentle, plant-based approach — with soy isoflavones, adaptogens, and evidence-backed botanicals traditionally used to support hormonal balance, energy, mood, and sleep. Formulated without hormones, these blends provide targeted relief tailored to each stage of the menopause transition.

For women seeking comprehensive nutritional support, we recommend stacking PERI or MENO with our TRINITY multi-nutrients. This combination ensures you get all the essential vitamins and minerals your body needs alongside the natural botanical benefits — supporting overall wellbeing without the risk of over-supplementation. Stacking in this way helps you create a balanced, effective daily routine tailored to your unique needs.

Supports hormonal balance

Soy isoflavones (40mg) act as gentle phytoestrogens that may help regulate hormonal activity during perimenopause, easing symptoms linked to fluctuating estrogen levels. Adaptogens like Siberian Ginseng (100mg) and Damiana Leaf (145mg) support the body’s natural stress response to hormonal shifts.

Reduces tiredness and supports energy

Amino acids such as L-Arginine, L-Glutamine, and Taurine (each 500mg) help support energy metabolism and reduce feelings of fatigue, giving you sustained vitality during the transitional phase.

Enhances mental focus and clarity

PERI’s amino acid blend promotes neurotransmitter synthesis, aiding concentration and cognitive performance — perfect for combating “brain fog” common in perimenopause.

Promotes emotional wellbeing and calm

Adaptogenic herbs Damiana and Siberian Ginseng help support mood balance and reduce stress, helping you stay calm and centered through hormonal ups and downs.

Supports hormonal balance and eases symptoms

Soy isoflavones (40mg) and Dong Quai Root Extract (50mg) provide gentle, natural support by mimicking estrogen to help reduce menopause symptoms like hot flashes, night sweats, and mood swings.

Promotes bladder and urinary health

A meaningful 500mg dose of Pumpkin Seed Extract helps strengthen bladder muscles and reduce overactivity, improving control and comfort during menopause.

Supports relaxation and better sleep

Hops (80mg) and Sage Leaf bring calming properties that may ease anxiety and promote restful sleep, helping you feel more refreshed and balanced.

Boosts energy and cellular health

Coenzyme Q10 (150mg) supports energy production at the cellular level, enhancing overall vitality and reducing fatigue common during menopause.

1. Santoro, N., & Randolph, J. F. (2011). Reproductive hormones and the menopause transition. Obstetrics and Gynecology Clinics of North America, 38(3), 455-466. doi:10.1016/j.ogc.2011.05.001

2. Freeman, E. W., Sammel, M. D., Lin, H., Gracia, C. R., & Kapoor, S. (2005). Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstetrics and Gynecology, 105(5 Pt 1), 1062-1071. doi:10.1097/01.AOG.0000158868.04062.e9

3. Manson, J. E., & Bassuk, S. S. (2011). The menopause transition and postmenopausal hormone therapy. In L. Goldman & A. I. Schafer (Eds.), Goldman-Cecil Medicine (24th ed., pp. 2107-2113). Philadelphia, PA: Elsevier.

4. Stanczyk, F. Z., & Clarke, N. J. (2014). Measurement of estradiol—challenges ahead. Journal of Clinical Endocrinology and Metabolism, 99(1), 56-58. doi:10.1210/jc.2013-2851

5. Sitruk-Ware, R. (2002). Pharmacological profile of progestins. Maturitas, 41(Suppl 1), S7-S14. doi:10.1016/S0378-5122(02)00089-0

6. Prior, J. C., Hitchcock, C. L., & Barr, S. I. (1998). Why are optimal oestrogen levels so important to ageing women? Medical Hypotheses, 50(3), 189-198. doi:10.1016/S0306-9877(98)90134-1

7. Euling, S. Y., Herman-Giddens, M. E., Lee, P. A., Selevan, S. G., Juul, A., Sørensen, T. I., & Swan, S. H. (2008). Examination of US puberty-timing data from 1940 to 1994 for secular trends: Panel findings. Pediatrics, 121(Suppl 3), S172-S191. doi:10.1542/peds.2007-1813D

8. Sharara, F. I., & McClamrock, H. D. (1999). Differences in the luteinizing hormone surge detected by different commercially available immunoassays used for ovulation prediction. Fertility and Sterility, 71(6), 1004-1007. doi:10.1016/S0015-0282(99)00137-6

9. Burger, H. G., & Hale, G. E. (2005). Androgen therapy in women: Risks and benefits. Journal of Steroid Biochemistry and Molecular Biology, 97(1-2), 5-8. doi:10.1016/j.jsbmb.2005.06.004

10. Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J. L., ... & Balser, J. (2009). Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause, 16(5), 907-922. doi:10.1097/gme.0b013e3181a9c446

11. Davis, S. R., & Burger, H. G. (2008). Clinical review: Testosterone therapy in women. Maturitas, 61(1-2), 56-61. doi:10.1016/j.maturitas.2008.09.00

12. Davison, S. L., Bell, R., Donath, S., Montalto, J. G., & Davis, S. R. (2005). Androgen levels in adult females: Changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology and Metabolism, 90(7), 3847-3853. doi:10.1210/jc.2005-0212

13. Labrie, F., Archer, D. F., Koltun, W., Vachon, A., Young, D., Frenette, L., ... & Portman, D. (2015). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause, 22(11), 1279-1296. doi:10.1097/GME.0000000000000488